Currently out of the existing stock ratings of Paul Matteis, 183 are a BUY (67.03%), 90 are a HOLD (32.97%).

Paul Matteis

Work Performance Price Targets & Ratings Chart

Analyst Paul Matteis, currently employed at STIFEL, carries an average stock price target met ratio of 54.78% that have a potential upside of 35.41% achieved within 211 days.

Paul Matteis’s has documented 547 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 31-Mar-2025.

Wall Street Analyst Paul Matteis

Analyst best performing recommendations are on AVDL (AVADEL PHARMACEUTICALS PLC).
The best stock recommendation documented was for AVDL (AVADEL PHARMACEUTICALS PLC) at 5/26/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.93 (86.92%) receiving and performance score of 869.16.

Average potential price target upside

of $36.98 (30.33%) on KRTX (KARUNA THERAPEUTICS).
of $35.76 (15.64%) on VRTX (VERTEX PHARMACEUTICALS).
of $33.2 (12.52%) on BIIB (BIOGEN).

ACAD ACADIA Pharmaceuticals ACOR Acorda Therapeutics ALKS Alkermes Plc ALNY Alnylam Pharmaceuticals ALXN Alexion Pharmaceuticals ATHA Athira Pharma BIIB Biogen BMRN Biomarin Pharmaceutical CERE Cerevel Therapeutics Holdings GWPH GW Pharmaceuticals plc IONS Ionis Pharmaceuticals KRTX Karuna Therapeutics NBIX Neurocrine Biosciences PRVL Prevail Therapeutics SAGE Sage Therapeutic VRTX Vertex Pharmaceuticals ZGNX Zogenix AVDL Avadel Pharmaceuticals PLC DYN Dyne Therapeutics KALV Kalvista Pharmaceuticals GMTX Gemini Therapeutics QURE Uniqure NV ALEC Alector PRTK Paratek Pharmaceuticals ABOS Acumen Pharmaceuticals ELYM Eliem Therapeutics WVE Wave Life Sciences Ltd XENE Xenon Pharmaceuticals AKCA Akcea Therapeutics AKAO Achaogen CDTX Cidara Therapeutics DNLI Denali Therapeutics NBRV Nabriva Therapeutics AG OREX Orexigen Therapeutics PEPG PepGen Ltd GHRS GH Research PLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ami Fadia (NEEDHAM)